National Cancer Center

Toray Industries, Inc.

Dainippon Sumitomo Pharma Co., Ltd.

Koken Company, Limited

Other

3-d Matrix, Ltd.

Daiichi Pharmaceutical Co., Ltd.

Sumitomo Chemical Company, Limited

Shiseido Company, Limited

Taisho Pharmaceutical Co., Ltd.

Sii Nanotechnology Inc.

Sumitomo Pharmaceuticals Company Limited

Asahi Kasei Pharma Corporation

Morinaga Milk Industry Co., Ltd.

Sumitomo Dainippon Pharma Co., Ltd.

Takahiro Ochiya

Tetsuya Ishikawa

Satoko Kozono

Hiroko Sudo

Junpei Kawauchi

Satoshi Kondou

Hitoshi Nobumasa

Nobuyoshi Kosaka

Hiroyuki Fujimoto

Masaaki Terada

Makiko Yoshimoto

Takumi Teratani

Juntaro Matsuzaki

Yuho Kida

Kenji Tamura

Makiko Ono

Atsuko Miyano

Shun-ichi Watanabe

Tomohiro Fujiwara

Fumihiko Urabe

Kimi Honma

Akihiko Sano

Makoto Tsukamoto

Tomoyasu Kato

Takashi Sugimura

Sho Yoshida

Wataru Usuba

Shunji Nagahara

Toshiaki Fujii

Teruo Miyata

Hiroshi Itoh

Kouji Iwasaki

Hiroyuki Wada

Masanao Munekane

Kikuya Kato

Yu Aso

Hiroyuki Tsuda

Hirohisa Izumi

Tomonobu Ezure

Yusuke Yamamoto

Akihiko Hisada

Naoomi Tominaga

Takeo Sekiya

Hiroyasu Toriyama

Fumitaka Takeshita

Makoto Asamoto

Masaki Kawamata

Yusuke Yoshioka

Kurataka Otsuka

Takeshi Katsuda

Ryou-u Takahashi

Yasuji Ueda

Keitaro Hagiwara

Kazunori Sekine

This application provides a kit or a device for detection of lung cancer, comprising a nucleic acid(s) for detecting a miRNA(s) in a sample from a subject, and a method for detecting lung cancer, comprising measuring the miRNA(s) in vitro.

Kit, device, and method for detecting lung cancer

It is intended to provide a kit or a device for the detection of breast cancer and a method for detecting breast cancer. The present invention provides a kit or a device for the detection of breast cancer, comprising nucleic acid(s) capable of specifically binding to a miRNA in a sample of a subject, and a method for detecting breast cancer, comprising measuring the miRNA in vitro.

Breast cancer detection kit or device, and detection method

The present invention relates to a microRNA expression promoting agent, containing pterostilbene, wherein the microRNA is at least one selected from the group consisting of miR-34a, miR-16, miR-126, miR-193b, and let-7a.

MicroRNA expression promoting agent and food or beverage for promoting expression of microRNA

This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.

Kit, device and method for detecting prostate cancer

An embodiment according to the present invention provides a kit or device for detection of bladder cancer, and a method for detecting bladder cancer. An embodiment according to the present invention relates to: a kit or device for detection of bladder cancer, including a nucleic acid(s) capable of specifically binding to an miRNA(s) or a complementary strand(s) thereof in a sample from a subject; and a method for detecting bladder cancer, including measuring the miRNA(s) in vitro.

Kit, device, and method for detecting bladder cancer

This application provides a kit or a device for detection of ovarian tumor, comprising a nucleic acid(s) for detecting a miRNA(s) in a sample from a subject, and a method for detecting ovarian tumor, comprising measuring the miRNA(s) in vitro.

Kit, device, and method for detecting ovarian tumor

The present invention is to provide a method of exosome analysis that can analyze exosome in a sample in a simple manner. The method of exosome analysis of the present invention is a method of analyzing exosome in a sample, including: an addition step of adding a first antibody that specifically binds to a first antigen contained in the exosome and a second antibody that specifically binds to a second antigen contained in the exosome to the sample; a reaction step of causing the first antigen to be reacted with the first antibody and the second antigen to be reacted with the second antibody; and a detection step of detecting a reaction between the first antigen and the first antibody and a reaction between the second antigen and the second antibody.

Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome

A method of examining a possibility of a subject having pancreatic cancer, including measuring GPRC5C (G protein-coupled receptor family C group 5 member C) present in an exosome in a specimen collected from the subject.

Method of examining possibility of subject having pancreatic cancer

An object of the present invention is to provide a kit or a device for the detection of prostate cancer and a method for detecting prostate cancer. The present invention provides a kit or a device for the detection of prostate cancer, comprising a nucleic acid capable of specifically binding to a miRNA in a sample of a subject, and a method for detecting prostate cancer, comprising measuring the miRNA in vitro.

Prostate cancer detection kit or device, and detection method

Growing community of inventors

Tokyo, Japan

Takahiro Ochiya